Pharmacokinetics News and Research

RSS
The term pharmacokinetics is derived from the ancient Greek words “pharmakon” and “kinetikos”, meaning “drug” and “putting in motion” respectively. It is one of the main branches of pharmacology, and refers to the way that the body reacts on and affects a pharmaceutical substance in the body.
New tau PET radiotracer shows promise for early detection of Alzheimer's disease

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

Improving treatment outcomes for individuals with acute spinal cord injury

Improving treatment outcomes for individuals with acute spinal cord injury

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

Experts call for changes to how drugs are tested and labeled for people with obesity

Experts call for changes to how drugs are tested and labeled for people with obesity

Engineered ACE2 decoy shows promise as COVID-19 treatment

Engineered ACE2 decoy shows promise as COVID-19 treatment

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

Illustrating the safety of a new drug treatment designed for spinal cord injury

Illustrating the safety of a new drug treatment designed for spinal cord injury

Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

Experimental drug can reduce symptoms of inflammatory bowel disease in pre-clinical models

Duke researchers develop potent antibiotic against drug-resistant superbugs

Duke researchers develop potent antibiotic against drug-resistant superbugs

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Embracing nature's medicine: exploring medicinal plants for diabetes treatment

Embracing nature's medicine: exploring medicinal plants for diabetes treatment

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

A novel pharmacology modeling approach to monitor acute lymphoblastic leukemia treatment

Understanding the mechanisms behind rising antifungal drug resistance

Understanding the mechanisms behind rising antifungal drug resistance

Clinical trial of three-month TB treatment regimen closed due to high rate of unfavorable outcomes

Clinical trial of three-month TB treatment regimen closed due to high rate of unfavorable outcomes

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Breast cancer drug development work moves forward with support from STTR grant

Breast cancer drug development work moves forward with support from STTR grant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.